Lucerastat(NBDGJ) is an orally available inhibitor of Glucosylceramide Synthase (GCS) with therapeutic potential for Fabry disease. GCS is a key enzyme in sphingolipid synthesis and inhibition of its activity reduces the accumulation of harmful substrates.
Molecular Weight:
219.28
Purity:
98.00%
CAS Number:
[141206-42-0]
Formula:
C10H21NO4
Target:
Transferase
T32923
T32923
* VAT and and shipping costs not included. Errors and price changes excepted